Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

IMPE Abstracts

Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

ICPE Plenary Lectures
- Paediatric endocrinology training in Sub-Saharan Africa – A 10 year journey from bench to the clinics
- - Abstract unavailable
    
    impe0096pl1
- Access to medicines
- - It’s not "all too hard"! Together we CAN improve access to essential paediatric endocrine medicines for all. A roadmap to 2030.
    
    impe0096pl2
- Prevention of T1D: How close are we?
- - Abstract unavailable
    
    impe0096pl3
- Genetics of extreme short stature
- - Abstract unavailable
    
    impe0096pl4
- The gut microbiome and novel approaches to childhood obesity
- - Is microbiome treatment for obesity and metabolic syndrome a possibility?
    
    impe0096pl5
- Gene therapy for pediatric diseases
- - Abstract unavailable
    
    impe0096pl6
- Advances in management of congenital bone disorders
- - Abstract unavailable
    
    impe0096pl7
- Neuroendocrine effects of environment disrupting chemicals
- - Abstract unavailable
    
    impe0096pl8
- Advances in diagnosis and management of monogenic diabetes
- - Abstract unavailable
    
    impe0096pl9
- Glial regulation of energy metabolism: diet-induced metabolic inflammation shapes feeding circuitry during development
- - Abstract unavailable
    
    impe0096pl10
- Genomic imprinting and its clinical relevance
- - Genomic imprinting and its clinical relevance: lesson from Kagami-Ogata syndrome and Temple syndrome
    
    impe0096pl11
- Genomics and beyond: Protein sequence structure and functional relationships underlying human disease
- - Abstract unavailable
    
    impe0096pl12
Symposia
- Management of T1D in Youth: Present and Future
- - Abstract unavailable
    
    impe0096s1.1
  - Macronutrient management in Type 1 Diabetes in Youth
    
    impe0096s1.2
  - Abstract unavailable
    
    impe0096s1.3
- Current Status of Complications in T1D in Youth
- - Update on retinopathy - should we screen or not?
    
    impe0096s2.1
  - Abstract unavailable
    
    impe0096s2.2
  - Abstract unavailable
    
    impe0096s2.3
- Obesity and Type 2 Diabetes in Youth: Update and controversies
- - Abstract unavailable
    
    impe0096s3.1
  - Abstract unavailable
    
    impe0096s3.2
  - Abstract unavailable
    
    impe0096s3.3
- Novel concepts in Disorders/Differences of Sexual Development
- - Abstract unavailable
    
    impe0096s4.1
  - Abstract unavailable
    
    impe0096s4.2
  - Clinical approach to DSD: individualised multidisciplinary care
    
    impe0096s4.3
- Role of IGFs in physiology and disease
- - Growth Hormone Action in Growth and Aging
    
    impe0096s5.1
  - PAPP-A2 in physiology and disease
    
    impe0096s5.2
  - Clinical and genetic evaluation of children with syndromic short stature
    
    impe0096s5.3
- Novel concepts in pediatric male and female gonadal dysfunction
- - Abstract unavailable
    
    impe0096s6.1
  - Abstract unavailable
    
    impe0096s6.2
  - Abstract unavailable
    
    impe0096s6.3
- Aromatase activity
- - Abstract unavailable
    
    impe0096s7.1
  - Abstract unavailable
    
    impe0096s7.2
  - Abstract unavailable
    
    impe0096s7.3
- New aspects in thyroid cancer
- - Abstract unavailable
    
    impe0096s8.1
  - Lessons from Fukushima: Current situation of thyroid cancer among children and adolescents after the Fukushima Daiichi Nuclear Power Plant accident
    
    impe0096s8.2
  - Abstract Unavailable
    
    impe0096s8.3
- Advances in Congenital Adrenal Dysfunction
- - Optimizing hormonal treatment in children and adolescents with congenital adrenal hyperplasia due to 21 hydroxylase deficiency
    
    impe0096s9.1
  - New perspectives for neonatal screening for congenital adrenal hyperplasia
    
    impe0096s9.2
  - Novel genes leading to congenital hypoadrenalism
    
    impe0096s9.3
- Hypothalamo-pituitary disease and development
- - Molecular Mechanisms of Congenital Hypopituitarism
    
    impe0096s10.1
  - Abstract unavailable
    
    impe0096s10.2
  - Abstract Unavailable
    
    impe0096s10.3
- Novel Bone Therapeutics
- - Abstract unavailable
    
    impe0096s11.1
  - Abstract unavailable
    
    impe0096s11.2
  - Abstract Unavailable
    
    impe0096s11.3
- Hypoglycaemia
- - Abstract unavailable
    
    impe0096s12.1
  - Abstract unavailable
    
    impe0096s12.2
  - Abstract Unavailable
    
    impe0096s12.3
- DOHaD: basics and beyond
- - Epigenetics and DOHaD: from basics to birth and beyond
    
    impe0096s13.1
  - Abstract unavailable
    
    impe0096s13.2
  - Abstract Unavailable
    
    impe0096s13.3
- Optimal, minimal and alternative actions for the diagnosis and treatment of endocrine problems in children in countries with limited resources
- - 100 Years after the Discovery of Insulin: Why the Urgent Need to Address Access to Insulin in Low- and Middle-Income Countries?
    
    impe0096s14.1
  - Allgrove Syndrome: Phenotype-Genotype correlation in patients from a resource-limited country
    
    impe0096s14.2
  - Abstract Unavailable
    
    impe0096s14.3
- Newborn Screening
- - Abstract unavailable
    
    impe0096s15.1
  - Abstract unavailable
    
    impe0096s15.2
  - Abstract Unavailable
    
    impe0096s15.3
Meet the Expert
- Clinical Approach to Sodium Homeostasis Disorders in Children with Pituitary-Suprasellar Tumors
- - Abstract unavailable
    
    impe0096mte1
- Management of the child/adolescent with an adrenal mass
- - Abstract unavailable
    
    impe0096mte2
- Diagnosis and Management of Rare Hypophosphataemic Rickets
- - Diagnosis and Management of Rare Hypophosphataemic Rickets
    
    impe0096mte3
- Diagnosis and management of congenital hypothyroidism under different socioeconomic contexts
- - Abstract unavailable
    
    impe0096mte4
- Management of Delayed Puberty
- - Abstract unavailable
    
    impe0096mte5
- Management of endocrine complications of adolescents with functional hypothalamic amenorrhea
- - Abstract unavailable
    
    impe0096mte6
- Management of Graves disease in children
- - Abstract unavailable
    
    impe0096mte7
- Fertility after childhood cancer (assessment, management and associated risks)
- - Fertility after childhood cancer
    
    impe0096mte8
- Management of growth disorders in non-GHD
- - Management of Growth Disorders in Non-GHD: Skeletal Dysplasia and Metabolic Bone Disease
    
    impe0096mte9
- Management of DKA in low income countries
- - Abstract unavailable
    
    impe0096mte10
How Do I…
- How Do I? 1 – Transition
- - Abstract unavailable
    
    impe0096hdi1.1
  - Macronutrient management in Type 1 Diabetes in Youth
    
    impe0096hdi1.2
  - How Do I ? Transition of Hypopituitarism/ GHD
    
    impe0096hdi1.3
- How Do I? 2 – Transgender
- - Abstract unavailable
    
    impe0096hdi2.1
  - Abstract unavailable
    
    impe0096hdi2.2
  - Abstract unavailable
    
    impe0096hdi2.3
Controversies
- T2D treatment – should we wait for approved medication?
- - Clinicians should muster the courage to use off-label medications when treating young patients with type 2 diabetes.
    
    impe0096con1.1
  - Controversies 1T2D treatment - should we wait for approved medication? For
    
    impe0096con1.2
- Cerebral salt wasting: Does it exist?
- - Abstract unavailable
    
    impe0096con2.1
  - Abstract unavailable
    
    impe0096con2.2
New Perspectives
- New perspectives in endocrine syndromes
- - Abstract unavailable
    
    impe0096np1.1
  - Genotype-based management for Noonan syndrome
    
    impe0096np1.2
- Mitochondrial diseases: do pediatric endocrinologists fail to recognize this condition?
- - Genetics of mitochondrial diseases: when the nucleus talks to the mitochondrion
    
    impe0096np2.1
  - Genetics of mitochondrial diseases: when the nucleus talks to the mitochondrion
    
    impe0096np2.2
- Gut hormones in childhood and adolescent obesity
- - Abstract unavailable
    
    impe0096np3.1
  - Abstract unavailable
    
    impe0096np3.2
Expert Panel
- Expert Panel 1
- - Abstract unavailable
    
    impe0096ex1.1
  - Abstract unavailable
    
    impe0096ex1.2
  - Abstract unavailable
    
    impe0096ex1.3
Free Communications
- GH and IGFs 1
- - Treatment with recombinant murine Pappa2, GH or IGF-1 modifies hepatic energy metabolism in a mouse model of Pappa2 deficiency
    
    impe0096fc1.1
  - Dose-dependent Increase in GH AUC_0-12h with LUM-201 in Idiopathic Pediatric GH Deficiency (iPGHD) from the Interim Analysis Data of the OraGrowtH212 Trial
    
    impe0096fc1.2
  - Age-Dependent and Sex-Specific Changes of DNA Methylation within Growth Hormone Receptor (GHR), Insulin-Like Growth Factor Type 1 Receptor (IGF1R) and Insulin Receptor (INSR) Gene Promoters in Peripheral Blood Leukocytes from Healthy Prepubertal and Pubertal Children
    
    impe0096fc1.3
  - Novel Insulin-Like Growth Factor 1 Gene Mutation: Broadening of The Phenotype and Implications for Insulin Resistance
    
    impe0096fc1.4
- Fetal and Neonatal Endocrinology
- - Increased catecholamines link fetal stress or growth restriction and neonatal hyperinsulinemic hypoglycemia: a prospective cohort study
    
    impe0096fc2.1
  - Gene expression profile analysis of the Umbilical cord derived mesenchymal stem cells revealed the difference in fetal programming between preterm SGA and term SGA
    
    impe0096fc2.2
  - EEG changes in children with congenital hyperinsulinism
    
    impe0096fc2.3
  - The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in the Manchester BabyGRO Study
    
    impe0096fc2.4
- Endocrinology of Sex Differences 1
- - Characterization and follow-up of a cohort of thirty patients with 46,XX testicular/ovotesticular disorders of sexual development
    
    impe0096fc3.1
  - Microdeletion within ESR1 constitutes a worldwide spread susceptibility factor for the development of undermasculinized genitalia
    
    impe0096fc3.2
  - DSD Interpreter, a mobile application-based tool for Point of Care evaluation of Atypical Genitalia
    
    impe0096fc3.3
  - The combination of FSH and markers of Sertoli cell function provides a high accuracy strategy to differentiate central hypogonadism from constitutional delay of puberty in boys: a longitudinal prospective study
    
    impe0096fc3.4
- Growth and Syndromes
- - Persistent and stable growth promoting effects of vosoritide in children with achondroplasia for up to 3.5 years: results from an ongoing Phase 3 extension study
    
    impe0096fc4.1
  - Low-dose infigratinib, an oral selective fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, demonstrates activity in preclinical models of FGFR3-related disorders
    
    impe0096fc4.2
  - Diagnostic yield of a multigene approach in children with short stature of unknown cause: It is time to remove the term idiopathic!
    
    impe0096fc4.3
  - Predicted Ratio of IGF-1 Observations and Differences in IGF-1 SDS Observations to 96-hour Values Over the Dosing Interval in Pediatric pGHD Patients Receiving Somatrogon
    
    impe0096fc4.4
- Fat, Metabolism and Obesity
- - Evaluation of Clinical Benefit Following Setmelanotide Treatment in Patients With Bardet-Biedl Syndrome
    
    impe0096fc5.1
  - The N221D Variant in PCSK1 is Highly Prevalent in Childhood Obesity and Can Influence Patients´ Metabolic Profile
    
    impe0096fc5.2
  - Development of Novel Anorexigenic and Glucoregulatory Chimeric Peptides
    
    impe0096fc5.3
  - Hepcidin is associated directly with inflammatory markers and inversely with glucose in Indigenous Argentinean children
    
    impe0096fc5.4
- Adrenals and HPA Axis 1
- - Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia
    
    impe0096fc6.1
  - Inhibiting the binding of ACTH to the Melanocorticotropin receptor by peptide to block androgen production
    
    impe0096fc6.2
  - Disruption of Pediatric Cushing Syndrome Evaluations by Heterophile Antibodies interfering with an Adrenocorticotropic Hormone (ACTH) Assay
    
    impe0096fc6.3
  - Development of a drug screening method for molecular targeted therapy of MIRAGE syndrome
    
    impe0096fc6.4
- Bone and Growth
- - Encaleret (CLTX-305) Normalized Mineral Homeostasis Parameters in Patients with Autosomal Dominant Hypocalcemia Type 1 over 12 months in a Phase 2 Study (NCT04581629)
    
    impe0096fc7.1
  - A new genetic cause of overgrowth syndrome
    
    impe0096fc7.2
  - Serum phosphorus levels as a driver of skeletal morbidity in patients with fibrous dysplasia
    
    impe0096fc7.3
  - Growth Hormone and Testosterone Improve Growth, Initiate Puberty, and Protect Against Vertebral Fractures in Children with Muscular Dystrophy on Chronic Glucocorticoids
    
    impe0096fc7.4
- Thyroid 1
- - Abstract unavailable
    
    impe0096fc8.1
  - Overexpression of Brachyury and IGF1R in Thyroid Papillary Carcinoma cells: different phenotypes and asocciation with pediatric Thyroid Nodular Pathology
    
    impe0096fc8.2
  - Sensitivity to thyroid hormones and cardiometabolic risk in euthyroid obese children: a cross-sectional study
    
    impe0096fc8.3
  - Custom next generation sequencing panel identifies somatic mutations and gene fusions in pediatric papillary thyroid carcinoma
    
    impe0096fc8.4
- Endocrinology of Sex Differences 2
- - Uncovering the role of the SF-1/NR5A1 p.Gly146Ala variant for the phenotype of DSD patients
    
    impe0096fc9.1
  - Self-reported Feelings of Adult Patients with Differences of Sex Development (DSD) Regarding Genital Surgical Procedures
    
    impe0096fc9.2
  - Mutation V631I in the Cytochrome P450 oxidoreductase (POR) alters steroid biosynthesis and drug metabolism
    
    impe0096fc9.3
  - The dose-dependent effect of estrogen on bone mineral density in trans girls
    
    impe0096fc9.4
- Miscellaneous
- - Clinical usefulness of a deep learning-based facial recognition application (Face2Gene) as a diagnostic tool for syndromic endocrine-related disorders
    
    impe0096fc10.1
  - Targeting androgen production by post-translational regulation of CYP17A1 lyase activity
    
    impe0096fc10.2
  - Pediatric hypercalcemia in a tertiary center
    
    impe0096fc10.3
  - Overlapping between dysnaetremias: Ibuprofen, a novel therapeutic key tool to control refractory polyuria – Case series
    
    impe0096fc10.4
- Diabetes and Insulin 1
- - Adolescents with type 2 diabetes experience significant diabetes-specific distress, poor emotional wellbeing and have unmet needs hindering optimal diabetes care
    
    impe0096fc11.1
  - RIAO as an early biomarker of β-cell failure and predictor biomarker of metabolic syndrome
    
    impe0096fc11.2
  - Metformin added to intensive insulin therapy improves Neuregulin-4 level and subclinical atherosclerosis in youth with type 1 diabetes
    
    impe0096fc11.3
  - Meal-induced activation of inflammatory pathways in youth with monogenic diabetes revealed by transcriptome analysis
    
    impe0096fc11.4
- GH and IGFs 2
- - Does early treatment with recombinant human growth hormone impact in visual assessment?
    
    impe0096fc12.1
  - PDE5 inhibitors may reverse the effects of isolated growth hormone deficiency caused by alternate splicing of the GH1 gene
    
    impe0096fc12.2
  - An in vivo functional assay to characterize human STAT5B genetic variants during zebrafish development
    
    impe0096fc12.3
  - In vitro funcional characterizationof two novel missense IGF1 variants
    
    impe0096fc12.4
- Adrenals and HPA Axis 2
- - Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-up
    
    impe0096fc13.1
  - Pubertal Outcome of 54 Children and Adolescents Treated For Adrenocortical Tumor: A Half of a Century Experience
    
    impe0096fc13.2
  - Differential methylation of CYP11B1 in girls with high DHEAS levels
    
    impe0096fc13.3
  - Comparing the single cell transcriptome of wild-type and 21-hydroxylase deficient murine adrenal glands
    
    impe0096fc13.4
- Miscellaneous Growth
- - Inborn Errors of Protein Metabolism: Longitudinal Data on Growth, Puberty, Bone Mineralisation, and Body Compositio
    
    impe0096fc14.1
  - Abstract Withdrawn
    
    impe0096fc14.2
  - Possible triggers related to the increased frequency of Idiopathic Central Precocious Puberty during and after COVID-19 confinement at the National Institute of Pediatrics in Mexico
    
    impe0096fc14.3
  - Pituitary Gigantism: Argentine experience
    
    impe0096fc14.4
- Puberty and Pituitary
- - Update on the etiological diagnosis of central precocious puberty in both sexes
    
    impe0096fc15.1
  - Several new candidate genes for self-limited delayed puberty revealed by whole exome sequencing
    
    impe0096fc15.2
  - The critical BMI hypothesis for puberty initiation and the gender prevalence difference: evidence from an epidemiological survey in Beijing, China
    
    impe0096fc15.3
  - Growth after discontinuation of GnRHa treatment for idiopathic central precocious puberty (ICPP): an analytical study of 100 Argentinian girls
    
    impe0096fc15.4
- Thyroid 2
- - A Retrospective Analysis of Patients with Pediatric Papillary Thyroid Cancer not Treated with RAI: Is Less More?
    
    impe0096fc16.1
  - Thyroid Monitoring Trends Following Iodine Exposure during Cardiac Intervention: Practices at a Large Urban Children’s Hospital
    
    impe0096fc16.2
  - Validation of Thyroid Interpreter, a mobile application-based tool in the diagnosis and management of thyroid disorders in childhood
    
    impe0096fc16.3
  - Thyroid Hormone Resistance: clinical case series
    
    impe0096fc16.4
- Diabetes and Insulin 2
- - T regulatory cells with engineered chimeric antigen receptor recognizing live human beta cells as a novel tool for development of type 1 diabetes therapies.
    
    impe0096fc17.1
  - Diabetes Stigma, Clinical Outcomes, and Substance Use in Adolescents and Young Adults: the SEARCH for Diabetes in Youth Study
    
    impe0096fc17.2
  - Pharmacologic inhibition of myostatin with a myostatin antibody protects against muscle and bone loss in an STZ-induced mouse model of type 1 diabetes
    
    impe0096fc17.3
  - Quantification of Liver Iron Measured by Magnetic Resonance in Adolescents with Type 2 Diabetes Mellitus
    
    impe0096fc17.4
Poster Presentations
- Adrenals and HPA Axis
- - Effect of a coenzyme in gene therapy for 21-hydroxylase deficiency with AAV vectors into a model mouse
    
    impe0096p1
  - Testicular function of 46,XY subjects with differences of sex development (DSD) due to NR5A1 mutations
    
    impe0096p2
  - Developing A Novel application using long read sequence for CYP21A2 gene analysis
    
    impe0096p3
  - Simultaneous determination of urinary catecholamines and free metanephrines by UHPLC-MSMS for diagnosis of pheochromocytomas and paragangliomas
    
    impe0096p4
  - Simple method for Mitotane determination in plasma samples by LC-DAD
    
    impe0096p5
  - Correlation of dried blood spot and plasma cortisol assays
    
    impe0096p6
  - Cortisol Stimulation Tests are Safe and Necessary for Diagnosing Central Adrenal Insufficiency
    
    impe0096p7
  - X-linked congenital adrenal hypoplasia: a clinical case report and description of a new complex rearrangement in the NR0B1 gene
    
    impe0096p8
  - Adult Height of 63 Children and Adolescents Treated for Adrenocortical Tumor Over 55 Years
    
    impe0096p9
  - Cortisol response in Non-Classic Congenital Adrenal Hyperplasia
    
    impe0096p10
  - Next Generation Sequencing (NGS) in The Diagnosis of PPGLs Associated with A Novel Germinal Variant in EPAS1
    
    impe0096p11
  - Clinical features of Congenital Adrenal Hyperplasia patients with Testicular Adrenal Rest Tumors
    
    impe0096p12
  - Cut-off point of basal 17-hydroxyprogesterone levels for the performance of ACTH stimulation testing in patients with suspected non-classical congenital adrenal hyperplasia
    
    impe0096p13
  - Adrenal finding in a patient with Klippel-Trenaunay syndrome
    
    impe0096p14
  - Cardiac paraganglioma in a pediatric patient: case report
    
    impe0096p15
  - Associations between puberty and physical development based on the outcomes of girls with earlier breast development
    
    impe0096p16
- Bone, Growth Plate and Mineral Metabolism
- - Association of Trabecular Bone Score and Bone Mineral Apparent Density with the Severity of Bone Fragility in Children and Adolescents with Osteogenesis Imperfecta: A Cross-sectional Study
    
    impe0096p17
  - Characterization of X-linked Hypophosphatemia in Latin America: Update from the Disease Monitoring Program
    
    impe0096p18
  - Serum alkaline phosphatase activity is correlated with the arm span to height ratio in the children with hypophosphatasia
    
    impe0096p19
  - Evaluation of The Trabecular Bone Score in 35 Children and Adults with X-Linked Hypophosphatemic Rickets
    
    impe0096p20
  - Orbit: A Randomized Phase 2/3 Study Consisting of a Phase 2 Single-Blind, Dose-Evaluation Phase and a Phase 3, Double-Blind, Placebo-controlled Phase to Assess the Efficacy and Safety of Setrusumab in Subjects with Osteogenesis Imperfecta
    
    impe0096p21
  - Hypophosphatemic rickets associated with the BCS1L gene
    
    impe0096p22
  - Efficacy and safety of equivalent doses of daily vs fortnightly oral vitamin D in treatment ofsymptomatic vitamin D deficiency in children aged 1-10 years: A Randomised controlled trial
    
    impe0096p23
  - Bone Mineral Density (BMD) at Final Height (FH) in Phenylketonuric (PKU) Patients
    
    impe0096p24
  - Comparison of bone mineral density before and after treatment for central precocious puberty
    
    impe0096p25
  - Genotype and Clinical Characteristics Analysis of Fourteen Chinese Short Stature Patients with ACAN Gene Variants
    
    impe0096p26
  - Sleep and Grow, Fact or Myth? The Effect of Melatonin-Stimulated Exosomes on Growth Plate in vitro Conditions
    
    impe0096p27
  - Bone Health and Associated Risk Factors in Transgender and Gender-Diverse Youth: an Argentine Cohort
    
    impe0096p28
  - Effects of burosumab on two siblings with mild X-linked hypophosphatemia
    
    impe0096p29
  - Neonatal Severe Hyperparathyroidism (NSHPT): A single centre experience from Western India
    
    impe0096p30
  - PTH resistance in a patient with 2q37 deletion syndrome and Albright hereditary osteodystrophy phenotype
    
    impe0096p31
  - Multicentric carpotarsal Osteolysis Syndrome (MCTO) diagnosed in two year old Argentinian girl with mutation de novo in gene MAFB
    
    impe0096p32
  - Novel Pathogenic NPR2 Variants in Short Stature Patients and the Therapeutic Response to rhGH
    
    impe0096p33
  - Bruck syndrome: Osteogenesis imperfecta with congenital conjoint contractures, case report.
    
    impe0096p34
  - Patient with cutaneous skeletal hypophosphatemia syndrome treated with Burosumab (monoclonal FGF23 antibody)
    
    impe0096p35
- Diabetes and Insulin
- - Clinical presentation of Japanese patients with KCNK16-MODY
    
    impe0096p36
  - Physical fitness and compliance of ADA/ISPAD Clinical Guideline Goals among children and adolescents with type 1 diabetes: the Diactive-1 Study
    
    impe0096p37
  - Single Nucleotide Polymorphism +276G>T of ADIPOQ gene and the occurrence of Associated Autoimmune Diseases in children and adolescents with Type 1 Diabetes Mellitus
    
    impe0096p38
  - Implementation of an advanced hybrid closed-loop system (MiniMed 780G) in children and adolescents with type 1 diabetes, in a national diabetes training center
    
    impe0096p39
  - Type 1 diabetes mellitus incidence in Chilean children between 2006 and 2021: significant increase during the COVID-19 pandemic years.
    
    impe0096p40
  - Sarcopenia in adolescents with diabetes mellitus
    
    impe0096p41
  - A comparative study of dental caries in children and adolescents with or without diabetes; an observational study in AbuDhabi, UAE
    
    impe0096p42
  - POC1A gene defect in two unrelated cases with severe dyslipidemic insulin resistance and SOFT syndrome
    
    impe0096p43
  - Long-term trends of pediatric type 1 diabetes incidence in Japan: before and during the COVID-19 pandemic years (1999–2021)
    
    impe0096p44
  - Evaluation of The Prevalence of Attention Deficit Disorder and Hyperactivity in Pediatric Patients with Type 1 Diabetes Mellitus Using Carbohydrate Counting
    
    impe0096p45
  - IMPACT of Type of Treatment on Health-Related Quality of Life in Children and Adolescents with T1D. A Multicenter Study in LIMA, Perú
    
    impe0096p46
  - Monogenic diabetes characterization in pediatric population from the last 10 years at Hospital Universitario del Valle, Cali Colombia
    
    impe0096p47
  - Safety and Glycemic Outcomes of MiniMed™ 780G Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes during Ramadan fasting: A randomized controlled trial
    
    impe0096p48
  - Effect on insulin sensitivity of combined oral hormonal contraceptives and progestin implant use in young women with T1D
    
    impe0096p49
  - Congenital diarrhea and diabetes due to NEUROG3 mutation: report of 2 cases
    
    impe0096p50
  - An Interactive E-Book Resource About Inpatient Pediatrics Diabetes Management for Medical Learners: Preliminary Results of a Pilot Study
    
    impe0096p51
- Fat, Metabolism and Obesity
- - Pubertal Development and Growth Spurt in Childhood Obesity: Real World Profiling in 1300 Patients
    
    impe0096p52
  - Heterozygous Rare Sequence Variants In Genes of The Leptin-Melanocortin Pathway are Highly Prevalent in Childhood Obesity But Do Not Associate with Distinctive Phenotypic Features
    
    impe0096p53
  - The stability of amino acids, free and acyl-carnitine in dried blood specimens stored after newborn screening
    
    impe0096p54
  - Association of gut microbiota and glucose metabolism in children with disparate degrees of adiposity
    
    impe0096p55
  - Associations of obesity with growth and puberty in children: a cross-sectional study in Fuzhou, China
    
    impe0096p56
  - Differential metabolomic changes in response to saturated and unsaturated fatty acids
    
    impe0096p57
  - Obesity Interpreter, A Mobile Application-Based Tool, Provides A Cost-Effective Point of Care Guidance for The Evaluation of Children and Adolescents with Obesity
    
    impe0096p58
  - Association Between Markers of Adiposity During Childhood and Puberty Onset in A Cohort of Latino Girls
    
    impe0096p59
  - Clinical Characteristics of Variants in POMC, PCSK1, LEPR, NCOA1, and SH2B1
    
    impe0096p60
  - Sarcopenia in children with acute leukemia was worsened after induction therapy
    
    impe0096p61
  - Physical and metabolic characteristics of adolescents with severe obesity referred for bariatric surgery; observational study from Abu Dhabi, United Arab Emirates
    
    impe0096p62
  - Secular trends in obesity and dyslipidemia in 10-year-old children: a long-term epidemiological survey over 27 years in Oita City, Japan
    
    impe0096p63
  - Comparing efficacy and safety of monthly vs daily administration of oral cholecalciferol to correct vitamin D deficiency in adolescents
    
    impe0096p64
  - Persistence of Metabolic Healthy phenotype in Metabolically Healthy Obese Indian children and adolescents
    
    impe0096p65
  - A novel variant in MRAP2 associated with severe early-onset obesity: a case report
    
    impe0096p66
- Fetal, Neonatal Endocrinology and Metabolism
- - Hematocrit correction: impact on neonatal screening (NS) for endocrinopathies
    
    impe0096p67
  - Paternally derived chromosome 6q24 triplication causes neonatal diabetes mellitus
    
    impe0096p68
  - Does neonatal hypoglycemia cause brain injury? – A cohort study on long-term neurodevelopmental outcome in former neonates with mild or severe hypoglycemia
    
    impe0096p69
  - Determination of gestational age-adjusted cut-off values for neonatal screening (NS) for congenital adrenal hyperplasia (CAH)
    
    impe0096p70
  - Continuous intravenous glucagon in children with congenital hyperinsulinism: A retrospective single center evaluation of effects and adverse effects
    
    impe0096p71
  - Does iodine excess affect fetal thyroid gland differently in early gestation? A prospective study on the impact of oil-soluble contrast hysterosalpingography on offspring’s thyroid function
    
    impe0096p72
  - Long-Acting Octreotide analogue (LAR) Treatment in Diazoxide Unresponsive Congenital Hyperinsulinism (CHI) – Short term outcome
    
    impe0096p73
  - Adrenal steroids profile by UHPLC-MS/MS in recalled infants of the newborn screening for Congenital Adrenal Hyperplasia
    
    impe0096p74
  - “Successful intrauterine treatment of fetal goiter associated with thyroid dyshormonogenesis: case report”
    
    impe0096p75
  - IGF2-OMAs are a potential cause of hypoglycemia in infants
    
    impe0096p76
  - Data from the Brazilian Registry of Congenital Hyperinsulinism - Association of Congenital Hyperinsulinism
    
    impe0096p77
- GH and IGFs
- - Mice with pappa2 deficiency exhibit a negative energy balance associated with disturbances in the hypothalamic control of food intake and altered hepatic lipid metabolism in a sex-specific manner
    
    impe0096p78
  - Estradiol and testosterone modulate GH sensitivity through SOCS1 and SOCS2 in HEPG2 cells
    
    impe0096p79
  - p.Gln207Arg GH1 allelic variant associated to GH deficiency and specific intronic region may be a modulator of GH secretion
    
    impe0096p80
  - Functional characterization of a novel intronic IGF1R gene variant.
    
    impe0096p81
  - Children with Growth Hormone Deficiency Who Completed Treatment with Lonapegsomatropin Approached or Exceeded Average Parental Height at Week 130 in the enliGHten Trial
    
    impe0096p82
  - Baseline Demographics of the OraGrowtH210 Trial Studying LUM-201 in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) Interim Analysis Data
    
    impe0096p83
  - Development of A Minimum Data Set for the Monitoring of Recombinant Human Growth Hormone (rhGH) Therapy in Children with Growth Hormone Deficiency (GHD)– A GloBE-Reg Initiative
    
    impe0096p84
  - Evaluation of Body Compositon and Trabecular Bone Score After rhgh Discontinuation During the Transition Period in Patients with Pituitary Insufficiency: Preliminary Results
    
    impe0096p85
  - Impact on IGF1R and RANKL expression and IGF-1 and IGFBP-3 serum levels of zoledronic acid treatment compared with pamidronate in children with Osteogenesis Imperfecta
    
    impe0096p86
  - Association of IGF with Growth and Cognitive Development Among Young Children in Rural Tanzania: A Secondary Analysis of the Early Life Interventions in Childhood Growth and Development In Tanzania (ELICIT) Study
    
    impe0096p87
  - Experts’ Priorities for Treatment of Pediatric Growth Hormone Deficiency – Results of an Expert Panel of Physicians from Latin America
    
    impe0096p88
  - Adherence to growth hormone treatment using a connected injection device in six countries from Latin America: real-world exploratory descriptive analysis of data from 2019 to 2021
    
    impe0096p89
  - Proposed criteria to guide the molecular study of the IGF-1 receptor gene (IGF1R)
    
    impe0096p90
  - Growth hormone therapy was effective and well-tolerated over the long-term in Japanese children with short stature due to Noonan syndrome: a multicentre, non-interventional post-marketing study
    
    impe0096p91
- Growth and Syndromes
- - A Randomized Controlled Trial of Vosoritide in in Infants and Toddlers with Achondroplasia
    
    impe0096p92
  - Medical complications in children with achondroplasia: learnings from PROPEL – a prospective clinical assessment study
    
    impe0096p93
  - Potentially pathogenic variants identified by next-generation sequencing in patients with short stature of unknown origin
    
    impe0096p94
  - Bone mineral density in a cohort of children with ACH participating in the PROPEL studies
    
    impe0096p95
  - Bone age in children with achondroplasia: findings from a cohort of children participating in the PROPEL studies
    
    impe0096p96
  - 6-Month Subcutaneous Leuprolide Acetate Achieved and Maintained Hormonal Suppression in Overweight Children
    
    impe0096p97
  - Girls with short statute and Xp22;Yq11 translocation: should a prophylactic gonadectomy be recommended?
    
    impe0096p98
  - Next generation sequencing implementation for the diagnosis of endocrine disorders: 4 years-experience in a public paediatric hospital
    
    impe0096p99
  - The Impact of Delaying Pubertal Development on Height Gain and Near Adult Height in Short Children born Small for Gestational Age (SGA) treated with Growth Hormone
    
    impe0096p100
  - A prospective genetic analysis of children with idiopathic short stature (ISS) using whole-exome sequencing (WES): first results
    
    impe0096p101
  - Trio whole-exome sequencing in patients with syndromic short stature of unknown cause
    
    impe0096p102
  - Beckwith-Wiedemann Syndrome with growth failure. An oxymoron or two different diagnoses?
    
    impe0096p103
  - Diagnostic implementation of the MS-MLPA technique in patients with clinical suspicion of Beckwith-Wiedemann and Silver Russell syndromes.
    
    impe0096p104
  - Familial Silver-Russell like Syndrome with postnatal microcephaly caused by a partial HMGA2 gene deletion
    
    impe0096p105
  - Current use of final height prediction methods among Chilean pediatric endocrinologists
    
    impe0096p106
- Multisystem Endocrine Disorders
- - Cushing Syndrome in patients with McCune-Albright Syndrome
    
    impe0096p107
  - Sphingosine-1-Phosphate Lyase Deficiency associated with Adrenal Insufficiency and Nephrotic Syndrome: two siblings with the same mutation and different clinical course
    
    impe0096p108
  - Nephrogenic syndrome of inappropriate diuresis: a case report of chronic euvolemic hyponatremia associated with activating mutation in the arginine vasopressin receptor AVPR2
    
    impe0096p109
  - Experience in Transition from pediatric to adult care in chronic endocrinological pathology in a general hospital. Endocrinology transition clinic
    
    impe0096p110
  - Congenital hypopituitarism and hyperinsulinism associated with FOXA2 deletion
    
    impe0096p111
- Pituitary, Neuroendocrinology and Puberty
- - Rapid Weight Gain in Early Life is Associated with Central Precocious Puberty; a Nationwide Population-based Study
    
    impe0096p112
  - Predicted structural destabilisation of GnRHR Arg139His pathogenic variant in a boy with hypogonadotrophic hypogonadism.
    
    impe0096p113
  - Rare plurihormonal Pit-1 adenoma presents as severe isolated clinical hyperthyroidism in 15 year old adolescent
    
    impe0096p114
  - Trends in Idiopathic Central Precocious Puberty (ICPP) incidence during the last decade and Covid19-pandemic lockdown impact. A case-control study.
    
    impe0096p115
  - Evaluation of Brain Nuclear Magnetic Resonance Findings in Patients with Apparently Idiopathic Central Precocious Puberty (Cpp) Aged Between 6 and 8 Years at Diagnosis
    
    impe0096p116
  - CBL-Related Disorder in A Boy with Microcephaly and Growth Hormone Deficiency
    
    impe0096p117
  - Clinical, anthropometric data and laboratory results of girls with precocious puberty before and during COVID-19 pandemic lockdown.
    
    impe0096p118
  - IMPACT of The COVID-19 Pandemic on The Incidence of Central Precocious Puberty: A Systematic Review
    
    impe0096p119
  - Abstract unavailable
    
    impe0096p120
  - Long term use of tolvaptan in a child with chronic SIADH secondary to intracranial teratoma
    
    impe0096p121
  - Did the prevalence of Central Precocious Puberty increase in girls during the Covid19 Pandemic? Comparison of cases diagnosed in a pediatric endocrinology service in Ciudad Autónoma de Buenos Aires in two periods: pre-pandemic and pandemic
    
    impe0096p122
  - Effect of weight change on the diagnosis of central precocious puberty
    
    impe0096p123
  - Clinical features, response to treatment and long-term follow-up of prolactinomas in children and adolescents: A retrospective single centre analysis
    
    impe0096p124
  - A multicentric study of germinoma with isolated pituitary stalk involvement during the pandemic of COVID-19 in Chile
    
    impe0096p125
  - Development and Validation of a Mobile Application-based assessment of Pubertal Disorders
    
    impe0096p126
  - Continuous arginine-vasopressin infusion during liver transplantation in a child with central diabetes insipidus and Langerhans cell histiocytosis.
    
    impe0096p127
  - Neuroendocrine Tumor as a cause of Ectopic Cushing Syndrome in pediatrics
    
    impe0096p128
  - Accuracy Subcutaneous Gonadotropin-Releasing Hormone Agonist (Triptorelin) Test compare with Intravenous Gonadorelin test for diagnosing central precocious puberty
    
    impe0096p129
  - Hypothalamic Hamartoma Series
    
    impe0096p130
  - Is Basal Luteinizing Hormone Level Accurate for Diagnosis of Central Precocious Puberty?
    
    impe0096p131
  - Craniopharyngioma Associated to Ocular and Brain Congenital Abnormalities
    
    impe0096p132
- Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
- - Treatment outcomes of gonadotropin-releasing hormone agonist in girls with central precocious puberty: Prediction of adult height using deep learning algorithm
    
    impe0096p133
  - Hashtag Hormones: Characterizing PCOS-Related Content on TikTok
    
    impe0096p134
  - Intervention effect of probiotics on the early onset of puberty induced by soy isoflavones
    
    impe0096p135
  - Differences of Sex Development Associated to Asymmetrical Overgrowth in a Patient with Chromosomal Mosaicism
    
    impe0096p136
  - Birth weight and height in individuals with SF-1/NR5A1 variants: Results from the international SF1next study
    
    impe0096p137
  - Pitfalls in the molecular diagnosis of 46, XY DSD complete gonadal dysgenesis
    
    impe0096p138
  - Clinical, Psychological, and Molecular Aspects of a Large Androgen Insensitivity Syndrome Cohort
    
    impe0096p139
  - The first familial case of the WT1 Zinc Finger domain 4 pathogenic variant
    
    impe0096p140
  - Low gonadotropins: a red flag in Klinefelter Syndrome
    
    impe0096p141
  - WT1 deletion in 46,XY DSD – the importance of copy number variant analysis
    
    impe0096p142
  - Ovarian cell dysfunction at diagnosis in girls with haematological malignancies
    
    impe0096p143
  - The Pre- and Postnatal Influence of Androgens in the Psychosexual Development of Classical Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency
    
    impe0096p144
  - Identification of The Minimum Dose of Human Chorionic Gonadotropin Hormone to Generate Positive Response in Patients with Differences in Sexual Development At The National Institute of Pediatrics in The Period 1990-2020
    
    impe0096p145
  - Survey of Australasian clinicians to assess current care provision models and the use of genetic testing in Differences of Sex Development (DSD)
    
    impe0096p146
  - 5 Alpha Reductase Deficiency: A Not So Uncommon Cause of 46XY DSD
    
    impe0096p147
  - 3B-hydroxysteroid dehydrogenase 2 (3BHSD2) deficiency 6 cases review
    
    impe0096p148
  - Identification of a novel variant in MYRF by NGS led to the detection of a clinically inapparent congenital heart disease in a patient with 46,XY DSD
    
    impe0096p149
  - Pathogenicity testing of fifteen novel missense SF-1/NR5A1 variants in DSD patients
    
    impe0096p150
  - Argentinian Transgender Children and Adolescents Cohort: an Eight Year Observational Multicenter Study
    
    impe0096p151
- Thyroid
- - A Tyrosine-kinase inhibitors (TKIs) treatment in sporadic Medullary Thyroid Cancer in a boy
    
    impe0096p152
  - Establishment and verification of pediatric thyrotrophin and thyroid hormones reference intervals using indirect methods
    
    impe0096p153
  - Hypothyroidism secondary to steroid-resistant nephrotic syndrome in children
    
    impe0096p154
  - Prognostic factors in papillary thyroid cancer, experience in a third level care hospital
    
    impe0096p155
  - Thyroid nodule cytology and malignancy risk in children and adolescents in a terciary centre.
    
    impe0096p156
  - Neurocognitive long-term follow-up of newborns with neonatal hyperthyroidism
    
    impe0096p157
  - Thyroid Storm Following Radioiodine Therapy in An Adolescent Girl: An Unusual Evolution
    
    impe0096p158
  - Thyroglossal duct cyst carcinoma in pediatric patient with Simpson Golabi Behmel syndrome: A possible causal relationship?
    
    impe0096p159
  - Severe Craneosynostosis in Non-Autoimmune Neonatal Hyperthyroidism, Suspected TSHR Activating Mutation, A Case Report
    
    impe0096p160
  - Diffuse Sclerosing Papillary Thyroid Carcinoma in An 8-Year-Old Girl. Five-Year Follow Up. ¿is it so Aggressive?
    
    impe0096p161
  - Screening of Autoimmunity and Thyroid Dysfunction in Asymptomatic Children and Adolescents With Non-Segmental Vitiligo
    
    impe0096p162
  - Association of infantile subclinical hypothyroidism and Pelizaeus-Merzbacher Disease.
    
    impe0096p163
  - Primary Hyperparathyroidism with Multiple Brown Tumors Mimicking Skeletal Metastasis. A Rare Case Report
    
    impe0096p164
  - Thyroid Function in Children Medicated with Carbamazepine
    
    impe0096p165
  - Poorly Differentiated Thyroid Carcinoma in Pediatrics, About A Case
    
    impe0096p166
  - Papillary thyroid carcinoma in a toxic nodular goiter appearing in a girl with Graves’ Disease: case report
    
    impe0096p167
ePoster Presentations
- Adrenals and HPA Axis
- - POR (P450 oxidoreductase) deficiency: report of a case
    
    impe0096ep1
  - Paraganglioma in pediatric patient: Case report of a 13-year-old Girl
    
    impe0096ep2
  - Avaliation of overwheigh frenquency in children and teenager with congenital adrenal hyperplasia
    
    impe0096ep3
  - Infant with primary hypoaldosteronism due to aldosterone synthase deficiency
    
    impe0096ep4
  - A Case with Late-Onset Familial Congenital Lipoid Adrenal Hyperplasia
    
    impe0096ep5
  - Adrenoleukodystrophy: A Case Report
    
    impe0096ep6
- Bone, Growth Plate and Mineral Metabolism
- - Primary hyperparathyroidism due to an atypical parathyroid adenoma in an adolescent. Case report
    
    impe0096ep7
  - Hypophosphatemic Rickets in a child with Ewings sarcoma following chemotherapy induced Fanconi syndrome
    
    impe0096ep8
  - Hereditary Hypomagnesemia with Secondary Hypocalcemia: A Case series from India
    
    impe0096ep9
  - Bone Health Index comparison before and after puberty induction in children with delayed puberty
    
    impe0096ep10
  - Challenges in Diagnosis and Management of Vitamin D Dependent Rickets Type 2; A Case Series from LMIC
    
    impe0096ep11
  - Recombinant Human Growth Hormone Treatment for Osteogenesis Imperfecta: A Case Report
    
    impe0096ep12
  - Prevalence of fractures and hypogonadotrophic hypogonadism in patients with Duchenne pathology
    
    impe0096ep13
  - A patient with McCune-Albright syndrome without endocrinological charge - the natural course of the disease.
    
    impe0096ep14
  - Case Report: Small Stature Associated with Uncertain Significance Variant of The IHH Gene
    
    impe0096ep15
  - Genu valgum deformity in a 12-year-old girl: the importance of an appropriate assessment in the diagnosis of rare diseases with genetic-bone-metabolic involvement
    
    impe0096ep16
  - Hypercalcemia Under Treatment with Recombinant Human Growth Hormone (rGH) in A Male Patient with Familial Hypocalciuric Hypercalcemia (FHH)
    
    impe0096ep17
- Diabetes and Insulin
- - Comparison of physical condition in adolescents with type 1 diabetes and general population in Chile
    
    impe0096ep18
  - Clinical and Laboratory Characteristics of Children with Type 1 Diabetes Mellitus Using Insulin Degludec
    
    impe0096ep19
  - FOXP3 Neonatal diabetes, case report
    
    impe0096ep20
  - 6q24-related Transient Neonatal Diabetes: future outcome and importance of genetic counseling
    
    impe0096ep21
  - Mauriac syndrome: a rare complicacation with an easy solution
    
    impe0096ep22
  - Monogenic Diabetes: A case series
    
    impe0096ep23
  - Neonatal Diabetes Mellitus in infant due to insulin gene mutation
    
    impe0096ep24
  - Glucokinase Gene Variant as A Cause of Mody Diabetes
    
    impe0096ep25
- Fat, Metabolism and Obesity
- - Assessment of The Nutritional Status and Food Consumption of Brazilian Girls with Central Early Puberty in Treatment with Leuprorelin Acetate During The COVID-19 Pandemic
    
    impe0096ep26
  - Frequency of depression in adolescents with obesity
    
    impe0096ep27
  - Familial hyperchylomicronemia due to lipoprotein lipase deficiency: dietary management
    
    impe0096ep28
  - Basilicata-Akhtar syndrome caused by a novel hemizygous variant in MSL3 gene: a case report
    
    impe0096ep29
  - Metabolic Disorders in Medicated Adolescents with Isotretinoin
    
    impe0096ep30
  - Burden of Paediatric Obesity and Associated Metabolic Complications in A Tertiary Care Hospital In India
    
    impe0096ep31
  - Hyperuricemia as a risk factor associated with metabolic syndrome in obese and overweight children
    
    impe0096ep32
- Fetal, Neonatal Endocrinology and Metabolism
- - Neonatal Screening Program In Argentina. 37 Years of experience at the Fundación de Endocrinología Infantil (FEI)
    
    impe0096ep33
  - Congenital Hyperinsulinism: review of cases after surgical treatment at the Hospital das Clínicas de Ribeirão Preto (HCRP), University of São Paulo
    
    impe0096ep34
  - Abstract unavailable
    
    impe0096ep35
  - Abstract unavailable
    
    impe0096ep36
  - Cyclic menses in a preterm infant
    
    impe0096ep37
  - Early diagnosis of Kabuki syndrome in an infant with congenital hyperinsulinism
    
    impe0096ep38
  - Knowledge of Pregnant Women About The Benefits of Breastfeeding for The Baby's Health in The Short and Long Term.
    
    impe0096ep39
  - Knowledge of Pregnant Women About "Developmental Programming" and The Importance of The 1000 Days for The Long-Term Health of The Baby
    
    impe0096ep40
  - Two cases of diffuse forms of diazoxide-responsive congenital hyperinsulinism with positive PET-CT findings
    
    impe0096ep41
  - Pseudohypoaldosteronism type 1, a diagnosis of difficult clinical suspicion. Case report
    
    impe0096ep42
- GH and IGFs
- - Daily growth hormone adherence and height velocity in children with pediatric growth hormone deficiency (pGHD) from a single-center institution in Minnesota, USA
    
    impe0096ep43
  - GH Stimulatory Tests for Diagnosing Isolated GH Deficiency
    
    impe0096ep44
  - The effect of growth hormone treatment on the body composition and metabolic profile in children born small for gestational age with short stature
    
    impe0096ep45
  - Pituitary Abnormality in Pediatric Growth Hormone Deficiency
    
    impe0096ep46
- Growth and Syndromes
- - A novel CNOT1 gene frameshift mutation causes Vissers-Bodmer syndrome
    
    impe0096ep47
  - Wiedemann-Steiner Syndrome: Case-report and review of literature
    
    impe0096ep48
  - Contiguous gene syndrome involving multisystem diseases characterized by short stature
    
    impe0096ep49
  - Assessment of growth and ventilatory sleep disorders in Prader Willi Syndrome patients with early onset of recombinant growth hormone treatment.
    
    impe0096ep50
  - Glucose metabolism in patients with short stature born small for gestational age (SGA) or with intrauterine growth restriction (IUGR) treated with recombinant human growth hormone (rhGH)
    
    impe0096ep51
  - Ring Chromosome 17 Syndrome and Its Growth Hormone Response: A Case Report
    
    impe0096ep52
  - A novel CEP57 variant associated with mosaic variegated aneuploidy syndrome type 2
    
    impe0096ep53
  - A rare homozygous IGFALS gene pathogenic variant: a case report
    
    impe0096ep54
  - Genotype and Clinical Characteristics Analysis of a Short Stature Patient with HUWE1 Gene Variants
    
    impe0096ep55
  - Noonan syndrome: a cause of short stature with cardiac manifestations and characteristic facial phenotype
    
    impe0096ep56
  - Long term follow-up of a child with McCune Albright syndrome
    
    impe0096ep57
  - Isolated growth hormone deficiency related to GH1 gene deletion: Case report and response to treatment with rhIGF1
    
    impe0096ep58
- Multisystem Endocrine Disorders
- - Dicer 1 Mutation: The Case of a Family
    
    impe0096ep59
  - New presentation of autoimmune polyglandular syndrome in a 4 years old child with Addison disease, autoimmune thyroiditis, and myasthenia gravis.
    
    impe0096ep60
- Pituitary, Neuroendocrinology and Puberty
- - Adipsic Diabetes Insipidus (ADI) in A Pediatric Patient with Panhypopituitarism Secondary to Craniopharyngioma: A Rare Manifestation Potentially Fatal
    
    impe0096ep61
  - Use of pasireotide in 15 year old female with pituitary gigantism and delayed bone age
    
    impe0096ep62
  - Searching mutations in pituitary adenomas – clinical presentation of 3 pediatric acromegalic patients
    
    impe0096ep63
  - Increased incidence of precocious and early accelerated puberty in females, during and after the Argentinian Covid-19 lock-down.
    
    impe0096ep64
  - Cushing’ disease in three patients with chronic kidney disease
    
    impe0096ep65
  - Novel mutation in AVP gene in a family with Autosomal Dominant Central Diabetes Insipidus
    
    impe0096ep66
  - Effectiveness of Triptorelin test compared to classic GnRH test when diagnosing central precocious puberty in girls
    
    impe0096ep67
  - Stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a case in pediatrics
    
    impe0096ep68
  - Efficacy and safety of triptorelin 3-month formulation in Chinese children with central precocious puberty: a 6-month open-label single-arm phase 3 study
    
    impe0096ep69
  - Arhinia, choanal atresia, microphthalmia and hypogonadism: case report
    
    impe0096ep70
- Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
- - Peripheral Precocious Puberty Due To Rare Form of Congenital adrenal hyperplasia,11 Beta Hydroxylase Deficiency (CYP11B1 MUTATION).
    
    impe0096ep71
  - Different faces of menarche praecox
    
    impe0096ep72
  - Retrospective analysis to describe characteristics of transgender children and adolescents referred to a pediatric endocrinology service
    
    impe0096ep73
  - Leydig cell hyperplasia in children: Case report
    
    impe0096ep74
  - Abnormal Uterine Bleeding Case Report
    
    impe0096ep75
  - Case Series of Neurofibromatosis Type 1 Presenting with Different Pubertal Presentation
    
    impe0096ep76
  - Etiological Characteristics of Patients with Sexual Development Disorders Seen at The Pediatric Endocrinology Service of A Tertiary Hospital
    
    impe0096ep77
  - Juvenile-type granulosa cell tumor in girls under 8 years of age: case reports
    
    impe0096ep78
  - Primary amenorrhea associated with Pringle-Bourneville Syndrome: a case report
    
    impe0096ep79
  - A special chromosome karyotype causes atypical Turner syndrome
    
    impe0096ep80
  - Knowledge and Attitudes of Medical Students Regarding Transsexuality
    
    impe0096ep81
- Thyroid
- - Falsely elevated concentration of TSH in a boy with central precocious puberty
    
    impe0096ep82
  - Familial medullary thyroid carcinoma, case report
    
    impe0096ep83
  - Slipped capital femoral epiphysis in a patient with hyperthyroidism: A novel endocrine association?
    
    impe0096ep84
  - Do Overweight and Obese Children Have Thyroid Dysmorphology?
    
    impe0096ep85
  - Follicular thyroid carcinoma in a child with hyperthyroidism
    
    impe0096ep86
  - Fetal goiter: a case report
    
    impe0096ep87

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

IMPE Abstracts

IMPE 2023

Contents

BiosciAbstracts